Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06593626
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-05-24
Brief Title:
A Phase I Clinical Study on the Safety and Pharmacokinetics of 18FFlorbetazine Injection
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase I Clinical Study on the Safety and Pharmacokinetics of 18FFlorbetazine Injection in Healthy Subjects and Patients with Amyloid Fibrils
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a phase-1 study that aims to evaluate the safety and pharmacokinetics of 18FFlorbetazine injection in healthy subjects and patients with MCI and AD
This study has evaluated and compared the distributed patterns of 18FFlorbetazine injection in healthy subjects and patients with AD and MCI
This study has evaluated and compared the distributed patterns of 18FFlorbetazine injection in healthy subjects and patients with AD and MCI
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None